Geode Capital Management’s iRadimed IRMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $27.7M | Buy |
290,109
+3,546
| +1% | +$323K | ﹤0.01% | 1968 |
|
|
2026
Q1 | $27.6M | Buy |
286,563
+24,598
| +9% | +$2.46M | ﹤0.01% | 1820 |
|
|
2025
Q4 | $25.5M | Sell |
261,965
-4,374
| -2% | -$375K | ﹤0.01% | 1881 |
|
|
2025
Q3 | $19M | Buy |
266,339
+4,953
| +2% | +$330K | ﹤0.01% | 2026 |
|
|
2025
Q2 | $15.6M | Buy |
261,386
+15,996
| +7% | +$877K | ﹤0.01% | 2090 |
|
|
2025
Q1 | $12.9M | Buy |
245,390
+22,618
| +10% | +$1.27M | ﹤0.01% | 2137 |
|
|
2024
Q4 | $12.3M | Buy |
222,772
+33,879
| +18% | +$1.78M | ﹤0.01% | 2237 |
|
|
2024
Q3 | $9.5M | Sell |
188,893
-1,568
| -0.8% | -$72.3K | ﹤0.01% | 2416 |
|
|
2024
Q2 | $8.37M | Buy |
190,461
+22,355
| +13% | +$951K | ﹤0.01% | 2433 |
|
|
2024
Q1 | $7.4M | Buy |
168,106
+9,901
| +6% | +$438K | ﹤0.01% | 2499 |
|
|
2023
Q4 | $7.51M | Buy |
158,205
+8,911
| +6% | +$375K | ﹤0.01% | 2486 |
|
|
2023
Q3 | $6.63M | Buy |
149,294
+6,736
| +5% | +$313K | ﹤0.01% | 2498 |
|
|
2023
Q2 | $6.81M | Buy |
142,558
+1,251
| +0.9% | +$56.4K | ﹤0.01% | 2527 |
|
|
2023
Q1 | $5.56M | Buy |
141,307
+7,396
| +6% | +$269K | ﹤0.01% | 2588 |
|
|
2022
Q4 | $3.79M | Buy |
133,911
+12,374
| +10% | +$354K | ﹤0.01% | 2799 |
|
|
2022
Q3 | $3.65M | Buy |
121,537
+825
| +0.7% | +$28.7K | ﹤0.01% | 2838 |
|
|
2022
Q2 | $4.1M | Buy |
120,712
+6,226
| +5% | +$223K | ﹤0.01% | 2808 |
|
|
2022
Q1 | $5.13M | Buy |
114,486
+5,391
| +5% | +$249K | ﹤0.01% | 2785 |
|
|
2021
Q4 | $5.04M | Buy |
109,095
+7,436
| +7% | +$300K | ﹤0.01% | 2898 |
|
|
2021
Q3 | $3.41M | Buy |
101,659
+5,176
| +5% | +$176K | ﹤0.01% | 3132 |
|
|
2021
Q2 | $2.84M | Buy |
96,483
+8,237
| +9% | +$227K | ﹤0.01% | 3162 |
|
|
2021
Q1 | $2.27M | Sell |
88,246
-29
| -0% | -$693 | ﹤0.01% | 3199 |
|
|
2020
Q4 | $2.01M | Buy |
88,275
+773
| +0.9% | +$17.9K | ﹤0.01% | 3083 |
|
|
2020
Q3 | $1.87M | Buy |
87,502
+1,980
| +2% | +$44.5K | ﹤0.01% | 2907 |
|
|
2020
Q2 | $1.98M | Buy |
85,522
+12,163
| +17% | +$261K | ﹤0.01% | 2843 |
|
|
2020
Q1 | $1.57M | Buy |
73,359
+4,533
| +7% | +$108K | ﹤0.01% | 2805 |
|
|
2019
Q4 | $1.61M | Buy |
68,826
+4,025
| +6% | +$94K | ﹤0.01% | 3099 |
|
|
2019
Q3 | $1.36M | Buy |
64,801
+4,709
| +8% | +$96.1K | ﹤0.01% | 3121 |
|
|
2019
Q2 | $1.23M | Buy |
60,092
+8,692
| +17% | +$205K | ﹤0.01% | 3173 |
|
|
2019
Q1 | $1.44M | Buy |
51,400
+5,578
| +12% | +$146K | ﹤0.01% | 3014 |
|
|
2018
Q4 | $1.12M | Buy |
45,822
+1,690
| +4% | +$45.4K | ﹤0.01% | 3065 |
|
|
2018
Q3 | $1.64M | Buy |
44,132
+9,783
| +28% | +$264K | ﹤0.01% | 2994 |
|
|
2018
Q2 | $712K | Buy |
34,349
+9,039
| +36% | +$160K | ﹤0.01% | 3312 |
|
|
2018
Q1 | $356K | Hold |
25,310
| – | – | ﹤0.01% | 3515 |
|
|
2017
Q4 | $383K | Hold |
25,310
| – | – | ﹤0.01% | 3456 |
|
|
2017
Q3 | $242K | Hold |
25,310
| – | – | ﹤0.01% | 3605 |
|
|
2017
Q2 | $217K | Sell |
25,310
-7,989
| -24% | -$68.2K | ﹤0.01% | 3652 |
|
|
2017
Q1 | $296K | Buy |
33,299
+1,811
| +6% | +$16.8K | ﹤0.01% | 3514 |
|
|
2016
Q4 | $349K | Buy |
31,488
+313
| +1% | +$3.37K | ﹤0.01% | 3404 |
|
|
2016
Q3 | $529K | Sell |
31,175
-93
| -0.3% | -$1.72K | ﹤0.01% | 3227 |
|
|
2016
Q2 | $680K | Buy |
31,268
+3,261
| +12% | +$58.7K | ﹤0.01% | 3080 |
|
|
2016
Q1 | $536 | Sell |
28,007
-2,862
| -9% | -$54.8K | ﹤0.01% | 3194 |
|
|
2015
Q4 | $864K | Buy |
30,869
+20,080
| +186% | +$568K | ﹤0.01% | 2991 |
|
|
2015
Q3 | $262K | Buy |
+10,789
| New | +$258K | ﹤0.01% | 3549 |
|
Other funds holding IRMD
CCM
NTCM
Geode Capital Management's IRMD Position: Q2 2026 in Review
Geode Capital Management increased its iRadimed (IRMD) stake by 1.2% in Q2 2026, buying an estimated $323K and bringing the position to 290,109 shares worth $27.7M. The position accounts for ﹤0.01% of the portfolio, ranked #1968.
Geode Capital Management first reported a position in IRMD in Q3 2015 and has held it in 44 quarters since. 203 funds tracked by Wall St. Rank hold IRMD as of Q2 2026.
- Geode Capital Management held 290,109 shares of iRadimed worth $27.7M as of Q2 2026.
- Geode Capital Management bought 3,546 iRadimed shares in Q2 2026, an estimated $323K.
- iRadimed made up ﹤0.01% of Geode Capital Management's portfolio in Q2 2026, its #1968 holding.
- Geode Capital Management first reported a position in iRadimed in Q3 2015 and has held it in 44 quarters since.
- 203 funds tracked by Wall St. Rank held iRadimed as of Q2 2026.
Based on Geode Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.